Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.55 SEK | +0.14% | +15.16% | -0.96% |
Apr. 26 | Nordic Shares Closed Up Friday; Medicover Series B Climbed Highest | DJ |
Apr. 25 | Transcript : NCAB Group AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Sales 2024 * | 4.08B 374M | Sales 2025 * | 4.46B 408M | Capitalization | 13.56B 1.24B |
---|---|---|---|---|---|
Net income 2024 * | 389M 35.61M | Net income 2025 * | 460M 42.11M | EV / Sales 2024 * | 3.43 x |
Net Debt 2024 * | 418M 38.22M | Net Debt 2025 * | 107M 9.78M | EV / Sales 2025 * | 3.07 x |
P/E ratio 2024 * |
34.9
x | P/E ratio 2025 * |
29.5
x | Employees | 585 |
Yield 2024 * |
1.5% | Yield 2025 * |
1.7% | Free-Float | 95.27% |
Latest transcript on NCAB Group AB
1 day | +0.14% | ||
1 week | +15.16% | ||
Current month | +3.42% | ||
1 month | +3.42% | ||
3 months | +5.45% | ||
6 months | +39.39% | ||
Current year | -0.96% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Kruk
CEO | Chief Executive Officer | 56 | 20-09-30 |
Anders Forsén
DFI | Director of Finance/CFO | 62 | 07-12-31 |
Jan Pedersen
CTO | Chief Tech/Sci/R&D Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Kruk
CEO | Chief Executive Officer | 56 | 20-09-30 |
Director/Board Member | 53 | 16-12-31 | |
Gunilla Rudebjer
BRD | Director/Board Member | 65 | 17-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 72.55 | +0.14% | 108,663 |
24-04-29 | 72.45 | -1.83% | 181,042 |
24-04-26 | 73.8 | +10.64% | 491,938 |
24-04-25 | 66.7 | +1.21% | 533,619 |
24-04-24 | 65.9 | +1.31% | 120,254 |
Delayed Quote Nasdaq Stockholm, April 30, 2024 at 06:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.96% | 1.23B | |
-2.27% | 48.42B | |
+19.54% | 11.53B | |
+51.45% | 8.85B | |
+3.41% | 8.5B | |
+8.15% | 7.71B | |
-20.18% | 7.49B | |
-11.07% | 6.98B | |
-13.27% | 6.81B | |
+31.60% | 6.62B |
- Stock Market
- Equities
- NCAB Stock